The global diabetic foot ulcer treatment market is anticipated to grow at a CAGR of around 7% during the forecast period. Diabetes is one of the critical causes of various diseases in adults. A diabetic foot ulcer is a frequent complication of diabetes mellitus. Approximately 25% of diabetic patients develop a diabetic foot ulcer in the lifetime as per one of the key players B. Braun, and the risk increases with the time. The market is driven by the increasing prevalence of diabetes among people along with the growing awareness regarding diabetes.
National Diabetes Statistics Report (2017) by the Centers for Disease Control and Prevention (CDC) states that around 30.3 million people had diabetes which was around 9.4% of the US population. Among these, 23.1 million people were diagnosed and 7.2 million people with diabetes were undiagnosed. A growing number of diagnosed populations have a positive impact on product demand. Diabetes causes foot ulceration which creates demand for various products for the treatment of foot ulcers and hence drives the growth of the global diabetic foot ulcer market during the forecast period. However, lack of awareness among the population regarding specific treatment options may hamper the growth of the DFU treatment market.
Segmental Outlook
The global Diabetic Foot Ulcer (DFU) market is segmented based on treatment type and ulcer type. Based on the treatment type, the market is sectioned as wound care dressings, biologics, antibiotic medications, therapy devices, and others. And based on the ulcer type, the market is sectioned as neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers.
Global Diabetic Foot Ulcer (DFU) Market by Treatment Type, 2018 (%)
Wound Care Dressings to Hold Significant Share in the Market
Amongst the treatment type of the market, the wound care dressings segment holds a significant share in the market during the forecast period. Wound care dressings include various types of dressings such as alginate dressings, Hydrofiber dressings, foam dressings, film dressing, hydrocolloid dressings, surgical dressings, and hydrogel dressings. Since increased cases of diabetes lead to a diabetic foot ulcer, there is an increased focus of key players in the R&D activities and developing innovative solutions for the treatment. For instance, in January 2018, Mölnlycke partnered with Tissue Analytics for the development of innovative digital solutions for wound care practitioners, which contributes towards the growth of the company as well as the market during the forecast period.
Regional Outlook
The global diabetic foot ulcer market is geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. The North American region is expected to hold the most significant share in the global diabetic foot ulcer market. This is attributed to the presence of large manufacturers such as 3M Co., Cardinal Health Inc., Integra LifeSciences Corp., Medline Industries Inc., and many others. These players contribute to the market by various technological advancements and developments, and product launches to drive the growth of the diabetic foot ulcer treatment market.
Moreover, increased incidences of diabetes lead to such problems which further enhances the growth of the regional market. Asia-Pacific region is projected to grow significantly in the global diabetic foot ulcer treatment market as there is a rise in the geriatric population, which are more prone to diseases especially in countries such as India, Japan,and China during the forecast period.
Global Diabetic Foot Ulcer Market by Region, 2018 (%)
Market player Outlook
The prominent players operating in the global diabetic foot ulcer market include 3M Co., B. Braun Melsungen AG, Coloplast A/S, ConvaTech Group PLC, Smith & Nephew Plc, Integra LifeSciences Corp., Mölnlycke Health Care AB, Acelity L.P. Inc., Cardinal Health Inc., and Medline Industries Inc. among others. These players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment. For instance, in July 2018 Mölnlycke acquired SastoMed GmbH for the expansion of their product offerings for enhancing the wound healing process and treating chronic wounds such as diabetic foot ulcers.
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. 3M Co.
3.2.1.1. Overview
3.2.1.2. Financial Analysis
3.2.1.3. SWOT Analysis
3.2.1.4. Recent Developments
3.2.2. B. Braun Melsungen AG
3.2.2.1. Overview
3.2.2.2. Financial Analysis
3.2.2.3. SWOT Analysis
3.2.2.4. Recent Developments
3.2.3. ConvaTec Group Plc
3.2.3.1. Overview
3.2.3.2. Financial Analysis
3.2.3.3. SWOT Analysis
3.2.3.4. Recent Developments
3.2.4. Coloplast A/S
3.2.4.1. Overview
3.2.4.2. Financial Analysis
3.2.4.3. SWOT Analysis
3.2.4.4. Recent Developments
3.2.5. Smith & Nephew Plc
3.2.5.1. Overview
3.2.5.2. Financial Analysis
3.2.5.3. SWOT Analysis
3.2.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Diabetic Foot Ulcer Treatment Market by Treatment
5.1.1. Wound Care Dressings
5.1.2. Biologics
5.1.3. Therapy Devices
5.1.4. Others
5.2. Global Diabetic Foot Ulcer Treatment Market by Ulcer Type
5.2.1. Neuropathic Ulcers
5.2.2. Ischemic Ulcers
5.2.3. Neuro-ischemic Ulcers
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3M Co.
7.2. B. Braun Melsungen AG
7.3. Cardinal Health, Inc.
7.4. Coloplast A/S
7.5. ConvaTec Group Plc
7.6. Essity AB
7.7. Hollister, Inc.
7.8. Integra LifeSciences Corp.
7.9. Izun Pharmaceuticals Corp.
7.10. Johnson & Johnson Services, Inc.
7.11. Medline Industries Inc.
7.12. Mölnlycke Health Care AB
7.13. Organogenesis, Inc.
7.14. Orpyx Medical Technologies Inc.
7.15. Paul Hartmann AG
7.16. Reapplix A/S
7.17. SANUWAVE Health, Inc.
7.18. Smith & Nephew Plc
1. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2018-2025 ($ MILLION)
2. GLOBAL WOUND CARE DRESSINGS FOR DIABETIC FOOT ULCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL BIOLOGICS FOR DIABETIC FOOT ULCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL THERAPY DEVICES FOR DIABETIC FOOT ULCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL OTHER TREATMENT FOR DIABETIC FOOT ULCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY ULCER TYPE, 2018-2025 ($ MILLION)
7. GLOBAL NEUROPATHIC ULCERS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL ISCHEMIC ULCERS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL NEURO-ISCHEMIC ULCERS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
11. NORTH AMERICAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
12. NORTH AMERICAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2018-2025 ($ MILLION)
13. NORTH AMERICAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY ULCER TYPE, 2018-2025 ($ MILLION)
14. EUROPEAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
15. EUROPEAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2018-2025 ($ MILLION)
16. EUROPEAN DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY ULCER TYPE, 2018-2025 ($ MILLION)
17. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
18. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2018-2025 ($ MILLION)
19. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY ULCER TYPE, 2018-2025 ($ MILLION)
20. REST OF THE WORLD DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2018-2025 ($ MILLION)
21. REST OF THE WORLD DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH AND ANALYSIS BY ULCER TYPE, 2018-2025 ($ MILLION)
1. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SHARE BY TREATMENT TYPE, 2018 VS 2025 (%)
2. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SHARE BY ULCER TYPE, 2018 VS 2025 (%)
3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
6. UK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
11. ROE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)